7 studies found for:    Open Studies | "Glucosephosphate Dehydrogenase Deficiency"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention: Dietary Supplement: non- fava beans
2 Recruiting Safety and Tolerability of Low Dose Primaquine
Conditions: Malaria, Falciparum;   G6PD Deficiency
Interventions: Drug: Dihydroartemisinin piperaquine (DHA PP);   Drug: Primaquine
3 Recruiting Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency
Condition: Neonatal Hyperbilirubinemia
Intervention: Drug: Yinzhihuang Oral Liquid
4 Not yet recruiting Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative
Conditions: Validation;   Biosensors;   Genotyping
Intervention:
5 Recruiting Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia
Condition: Malaria
Interventions: Drug: Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient individuals;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient individuals;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient individuals;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD normal individuals;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD normal individuals
6 Not yet recruiting A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Chloroquine
7 Recruiting The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders
Conditions: Hemolytic Disorders;   Gallstones
Intervention: Drug: Ursodeoxycholic Acid

Indicates status has not been verified in more than two years